These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 33291807

  • 1. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
    Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC.
    Toxins (Basel); 2020 Dec 04; 12(12):. PubMed ID: 33291807
    [Abstract] [Full Text] [Related]

  • 2. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Dec 04; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 4. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 31; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 5. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K, Dressler D, Woldag H, Koßmehl P, Koch M, Maisonobe P, Reichel G.
    Nervenarzt; 2019 Apr 31; 90(4):361-370. PubMed ID: 30324541
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L, Jacinto J, Fheodoroff K, Brashear A, Maisonobe P, Lysandropoulos A, Ashford S, Upper Limb International Spasticity (ULIS-III) study group.
    J Rehabil Med; 2021 Feb 24; 53(2):jrm00157. PubMed ID: 33616192
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH, Hefter H, Reissig A, Kollewe K, Wissel J.
    J Neurol Sci; 2014 Feb 15; 337(1-2):86-90. PubMed ID: 24361062
    [Abstract] [Full Text] [Related]

  • 8. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE, Baikova A, Maisonobe P, Khasanova DR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021 Feb 15; 121(11):39-48. PubMed ID: 34932284
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S, Alila S, Elleuch W, Ayed HB, Mhiri C, Elleuch MH.
    Pan Afr Med J; 2020 Feb 15; 35():55. PubMed ID: 32523646
    [Abstract] [Full Text] [Related]

  • 10. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D, Winter A, Fini N, Dixon C, Aldous S, Palit M, Holland AE.
    Disabil Rehabil; 2016 Sep 15; 38(19):1927-33. PubMed ID: 26714558
    [Abstract] [Full Text] [Related]

  • 11. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
    Borg J, Ward AB, Wissel J, Kulkarni J, Sakel M, Ertzgaard P, Åkerlund P, Reuter I, Herrmann C, Satkunam L, Wein T, Girod I, Wright N, BEST Study Group.
    J Rehabil Med; 2011 Jan 15; 43(1):15-22. PubMed ID: 21174051
    [Abstract] [Full Text] [Related]

  • 12. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 15; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F.
    J Rehabil Med; 2014 Sep 15; 46(8):730-7. PubMed ID: 25073939
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A.
    J Rehabil Med; 2009 Jun 15; 41(7):536-44. PubMed ID: 19543664
    [Abstract] [Full Text] [Related]

  • 15. [The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients].
    Khat'kova SE, Khasanova DR, Korenko LA, Antipova LN, Shperling LP, Popov DV, Pokhabov DV, Poznyakova EV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Jun 15; 115(7):89-97. PubMed ID: 26356520
    [Abstract] [Full Text] [Related]

  • 16. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J, Rubin JM, Chen J, O'Dell M.
    Ultrasound Med Biol; 2019 May 15; 45(5):1094-1102. PubMed ID: 30898386
    [Abstract] [Full Text] [Related]

  • 17. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A, Cinone N, Panza F, Letizia S, Santoro L, Lozupone M, Daniele A, Picelli A, Baricich A, Intiso D, Ranieri M.
    Drugs; 2019 Feb 15; 79(2):143-160. PubMed ID: 30623347
    [Abstract] [Full Text] [Related]

  • 18. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE, Knutzen A, Kühl C, Möller B, Hellriegel H, Margraf NG, Deuschl G, Stolze H.
    Brain Inj; 2017 Feb 15; 31(1):75-82. PubMed ID: 27880052
    [Abstract] [Full Text] [Related]

  • 19. Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning.
    Antón MJ, Molina M, Pérez JG, Pina S, Tapiador N, De La Calle B, Martínez M, Ortega P, Ruspaggiari MB, Tudela C, Conejo M, Leno P, López M, Marhuenda C, Arias-Cabrales C, Maisonobe P, Herrera A, Candau E.
    Toxins (Basel); 2024 Aug 02; 16(8):. PubMed ID: 39195750
    [Abstract] [Full Text] [Related]

  • 20. Real-world analysis of botulinum toxin (BoNT) injections in post-stroke spasticity: Higher doses of BoNT and longer intervals in the early-start group.
    Woo J, Mas MF, Zhang J, Wong B, Stampas A, Francisco GE, Li S.
    J Neurol Sci; 2021 Jun 15; 425():117449. PubMed ID: 33878656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.